» Articles » PMID: 19557500

Evaluation of Neo-angiogenesis in a Case of Chordoid Meningioma

Overview
Journal J Neurooncol
Publisher Springer
Date 2009 Jun 27
PMID 19557500
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chordoid is a rare variant of meningioma that displays a high recurrence rate. In this study we evaluated the immunohistochemical expression of factors that regulate the neo-angiogenesis process in a case of chordoid meningioma with an adverse clinical course. A high microvessel density (MVD), as well as high VEGF and VEGF-R1 expression, was encountered in this tumor. By contrast, the anti-angiogenic factor semaphorin3A, highly expressed in this chordoid meningioma, was ineffective because of the absence of its receptor neuropilin-1. We suggest that VEGF expression and MVD may represent significant prognostic factors in chordoid meningiomas.

Citing Articles

Role of bevacizumab for treatment-refractory meningiomas: A systematic analysis and literature review.

Franke A, Skelton Iv W, Woody L, Bregy A, Shah A, Vakharia K Surg Neurol Int. 2018; 9:133.

PMID: 30090665 PMC: 6057170. DOI: 10.4103/sni.sni_264_17.


Perfusion computed tomography of intracranial meningiomas: In vivo correlation of cerebral blood volume and vascular permeability.

Granata F, Morabito R, Alafaci C, Barresi V, Tomasello F, Vinci S Neuroradiol J. 2015; 28(3):303-9.

PMID: 26246100 PMC: 4757289. DOI: 10.1177/1971400915592551.


Chordoid meningioma: a retrospective series of seven consecutive cases.

Passacantilli E, Lapadula G, Caporlingua F, Lenzi J, Antonelli M, Santoro F Neurol Sci. 2013; 34(11):1985-9.

PMID: 23595544 DOI: 10.1007/s10072-013-1431-8.


Bevacizumab therapy for adults with recurrent/progressive meningioma: a retrospective series.

Lou E, Sumrall A, Turner S, Peters K, Desjardins A, Vredenburgh J J Neurooncol. 2012; 109(1):63-70.

PMID: 22535433 PMC: 3404217. DOI: 10.1007/s11060-012-0861-0.


Chordoid meningioma in a patient with lymphangioleiomyomatosis.

Campos-Franco J, Otero E, Lopez-Garcia E, Abdulkader I, Gonzalez-Quintela A J Neurooncol. 2011; 105(3):667-9.

PMID: 21643986 DOI: 10.1007/s11060-011-0622-5.


References
1.
Luo Y, Raible D, Raper J . Collapsin: a protein in brain that induces the collapse and paralysis of neuronal growth cones. Cell. 1993; 75(2):217-27. DOI: 10.1016/0092-8674(93)80064-l. View

2.
Perry A, Stafford S, Scheithauer B, Suman V, Lohse C . Meningioma grading: an analysis of histologic parameters. Am J Surg Pathol. 1997; 21(12):1455-65. DOI: 10.1097/00000478-199712000-00008. View

3.
Perry A, Scheithauer B, Stafford S, Lohse C, Wollan P . "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications. Cancer. 1999; 85(9):2046-56. DOI: 10.1002/(sici)1097-0142(19990501)85:9<2046::aid-cncr23>3.0.co;2-m. View

4.
Guttmann-Raviv N, Shraga-Heled N, Varshavsky A, Guimaraes-Sternberg C, Kessler O, Neufeld G . Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem. 2007; 282(36):26294-305. DOI: 10.1074/jbc.M609711200. View

5.
Couce M, Aker F, Scheithauer B . Chordoid meningioma: a clinicopathologic study of 42 cases. Am J Surg Pathol. 2000; 24(7):899-905. DOI: 10.1097/00000478-200007000-00001. View